Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C K TASHIMA

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reports|January 1, 1979
Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancerA U Buzdar, S S Legha, C K Tashima, et al.
Cancer|February 1, 1978
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapyA U Buzdar, C K Tashima, G R Blumenschein, et al.
Cancer Treatment Reports|May 1, 1979
High-dose methotrexate for advanced breast cancerH Y Yap, G R Blumenschein, B S Yap, et al.
Journal of Surgical Oncology|January 1, 1979
Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinomaA N Krutchik, A U Buzdar, G R Blumenschein, et al.
American Journal of Clinical Oncology|January 1, 1990
Pirarubicin in combination chemotherapy for metastatic breast cancerG N Hortobagyi, R L Theriault, D Frye, et al.
Cancer|March 1, 1979
Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisoleG N Hortobagyi, J U Gutterman, G R Blumenschein, et al.
Cancer|November 1, 1979
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCGG N Hortobagyi, J U Gutterman, G R Blumenschein, et al.
Cancer|April 1, 1979
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCGG N Hortobagyi, J U Gutterman, G R Blumenschein, et al.
Cancer|February 15, 1980
Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinomaG R Blumenschein, G N Hortobagyi, S P Richman, et al.
Cancer|March 1, 1978
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancerA U Buzdar, J U Gutterman, G R Blumenschein, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reports|January 1, 1979
Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancerA U Buzdar, S S Legha, C K Tashima, et al.
Cancer|February 1, 1978
Mitomycin-C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapyA U Buzdar, C K Tashima, G R Blumenschein, et al.
Cancer Treatment Reports|May 1, 1979
High-dose methotrexate for advanced breast cancerH Y Yap, G R Blumenschein, B S Yap, et al.
Journal of Surgical Oncology|January 1, 1979
Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinomaA N Krutchik, A U Buzdar, G R Blumenschein, et al.
American Journal of Clinical Oncology|January 1, 1990
Pirarubicin in combination chemotherapy for metastatic breast cancerG N Hortobagyi, R L Theriault, D Frye, et al.
Cancer|March 1, 1979
Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisoleG N Hortobagyi, J U Gutterman, G R Blumenschein, et al.
Cancer|November 1, 1979
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCGG N Hortobagyi, J U Gutterman, G R Blumenschein, et al.
Cancer|April 1, 1979
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCGG N Hortobagyi, J U Gutterman, G R Blumenschein, et al.
Cancer|February 15, 1980
Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinomaG R Blumenschein, G N Hortobagyi, S P Richman, et al.
Cancer|March 1, 1978
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancerA U Buzdar, J U Gutterman, G R Blumenschein, et al.
Pageof 4